[Management of pregnancy in patients with systemic lupus erythematosus]

Rev Clin Esp. 2012 Nov;212(10):491-8. doi: 10.1016/j.rce.2011.11.003. Epub 2012 Jan 14.
[Article in Spanish]

Abstract

Patients with systemic lupus erythematosus are exposed to a remarkably high number of maternal-fetal complications during pregnancy. Knowledge regarding the reciprocal influence between lupus and pregnancy is the starting point to assure that these patients are correctly monitored. It is also important to carry out comprehensive preconception evaluation to individually evaluate the risk of each patient. The immunological profile, history of nephritis, presence of chronic damage and disease activity are the basic data that will determine the specific individual risk profile. Finally, correct drug management must be assured during this period, based on the safety profile of the different treatments during pregnancy and lactation.

Publication types

  • Case Reports
  • English Abstract
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adult
  • Anti-Inflammatory Agents / therapeutic use*
  • Breast Feeding
  • Female
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Lupus Erythematosus, Systemic / drug therapy*
  • Postnatal Care / methods*
  • Pregnancy
  • Pregnancy Complications / drug therapy*
  • Pregnancy Complications / etiology
  • Pregnancy Complications / prevention & control
  • Prenatal Care / methods*

Substances

  • Anti-Inflammatory Agents
  • Immunosuppressive Agents